PROphet^®

PROphet^® Technology

PROphetNSCLC^TM Test

Resources

Clinical studies

Thought Leadership

Meetings & Events

Israel openings

PROphet^®

PROphet^® Technology PROphetNSCLC^TM Test

Resources

For Patients For Providers For Pharma

Science

Publications Presentations Clinical Studies Collaborators

News

In the News Thought Leadership Press Releases Meetings & Events Awards

Company

About us Careers Contact us

Thought Leadership

Meetings & Events

In the News

AI tool helps doctors pick optimum cancer treatment for patients

Observational study demonstrates clinical validity and utility of OncoHost’s PROphet NSCLC test

Study in JCO® Precision Oncology Validates Clinical Efficacy of OncoHost’s PROphet® NSCLC Test

Study Demonstrates Clinical Validity of OncoHost’s NSCLC Test

OncoHost Wins AI Excellence Award

February 26, 2024

Predicting immunotherapy success via biomarkers

February 22, 2024

New cancer research for personalized care

February 22, 2024

Study: Protein Indicates Likely Success of Cancer Immunotherapy

January 26, 2024

OncoHost’s CEO Is PROphet-ic About His Diagnostic’s Potential To Transform Care

January 15, 2024

OncoHost: Guiding oncology treatment decisions with one blood draw

January 4, 2024

Predicting Immune-Related Adverse Events Through Machine Learning With OncoHost: Dr. Waqas Haque, Dr. Matthew Hadfield, and Dr. Ofer Sharon

AI & Big Data - A Bright New Diagnosis? Roundtable

December 8, 2019

First-Of-Its-Kind Lab To Improve Personalized Cancer Therapy Opens In Israel

December 31, 2019

Israeli algorithm may predict if cancer patients will respond to treatment

January 21, 2020

OncoHost, RayBiotech Win $1M From BIRD Foundation

January 21, 2020

OncoHost, RayBiotech Awarded $1 Million Grant for Precision Oncology

February 5, 2020

Top 5 Recent Advances In Israeli Cancer Research And Treatment

February 10, 2020

Startup develops blood test that aims to undermine tumors’ resilience

February 18, 2020

Backed by EU funds, Israeli researcher tackles treatment-resistant cancer

February 23, 2020

$8m in BIRD grants go to Israeli-US collaborations in agtech and health

Personalized Cancer Treatment, A Real Possibility?

Developing Personalized Strategies To Maximize Cancer Therapy Success

PART 1: Yuval Shaked, ASCO 2020: Host Response Profiling for Melanoma Patients

PART 2: Yuval Shaked, ASCO 2020: Host Response Profiling for Melanoma Patients

By Next Year, Will Doctors Finally Have The Technology To Fully Personalize Treatments For Lung Cancer Patients?

October 6, 2020

OncoHost Data on Host Immunotherapy Response to be Presented This Week

November 4, 2020

Oncohost platform improves immunotherapy response predictions

November 12, 2020

Israeli blood test offers better choices to fight cancer

November 15, 2020

OncoHost Offers New Hope For Cancer Sufferers

December 8, 2020

Dr. Ofer Sharon, CEO of OncoHost – Interview Series

December 31, 2020

OncoHost - Personalized cancer therapy for more effective treatment

January 12, 2021

Nobel prizewinner Ciechanover hails ‘much more precise’ cancer treatment

January 19, 2021

Israeli Startup OncoHost Raises $8M For AI Precision Oncology Platform

January 19, 2021

Israel-based OncoHost closes $8M in Series B funding to provide personalized cancer therapy for more effective treatment

January 19, 2021

OncoHost Raises $8 Million in Series B Funding Round

January 19, 2021

OncoHost raises $8 million to develop AI that predicts cancer treatment responses

January 20, 2021

OncoHost Secures $8M in Series B Funding

January 20, 2021

The evolution of machine learning in oncology: an interview with Dr Ofer Sharon

January 21, 2021

Money on the Move: January 15-20

January 26, 2020

US-Israel Foundation To Invest $8M In 9 New Joint Initiatives

January 21, 2021

OurCrowd leads $8M Series B in Israeli personalized cancer therapy startup

January 22, 2021

Oncohost nabs $8M series B round for AI-powered precision oncology platform

January 22, 2021

OncoHost Secures $8 Million Series B Funding Round

January 26, 2021

Health IT Appointments and Hires

February 1, 2021

January 2021 smiles upon Israeli startups: 4 new Unicorns and over $1B in funding

February 17, 2021

Dr. Ofer Sharon, CEO of OncoHost, Discusses Technology to Improve Cancer Care

How an AI tool predicts responses to cancer treatment

Which Israeli technologies will soon be going to space?

The Impact of Technology on Healthcare

NHS opens eight UK clinical trial sites to assess cancer patient response to immunotherapy in collaboration with OncoHost

NHS Opens Eight UK Clinical Trial Sites to Assess Cancer Patient Response to Immunotherapy in Collaboration with OncoHost

NHS opens 8 clinical trial sites to assess cancer treatment

Israel’s OncoHost, UK’s NHS to study cancer patient responses to immunotherapies

Oncohost opens trial sites for study evaluating its AI proteomics profiling technology

OncoHost's Focus on the Patient Offers Precision Oncology to Combat Cancer

August 19, 2021

OncoHost awarded Best Practices Technology Innovation Leadership Award in the AI-based precision oncology industry by Frost & Sullivan

August 20, 2021

OncoHost Wins Frost & Sullivan 2021 Technology Innovation Leadership Award for Excellence in Best Practices

August 25, 2021

Israeli Startup OncoHost Eyeing 2022 Commercial Launch of Immunotherapy Response Prediction Test

September 20, 2021

OncoHost Further Assessing Protein Signature for Predicting NSCLC Patients' Immunotherapy Response

September 20, 2021

Oncohost platform predicts response to lung cancer therapy

October 31, 2021

OncoHost’s Algorithms Predict Cancer Patients Response To Treatments

November 1, 2021

CTech’s 20 Minute Leaders Podcast Interview with Ofer Sharon, CEO of OncoHost

November 6, 2021

OncoHost: Personalizing cancer treatment based on host response

November 15, 2021

Dr. Ofer Sharon, CEO of OncoHost, Talks the Potential Impact of Precision Medicine on Cancer Therapy

December 1, 2021

OncoHost: David Gandara

December 7, 2021

Health IT Appointments and Hires

December 13, 2021

OncoHost, Heidelberg University Hospital Strike Lung Cancer Biomarker Alliance

December 16, 2021

Global Roundup: Aussie Biopharma Raises $25 Million to Expand in US

December 17, 2021

Israeli research institute makes great contributions to cancer research

December 20, 2021

OncoHost Collaborates with Lung Biobank Heidelberg to Discover Lung Cancer Biomarkers

January 17, 2022

OncoHost Announces Interim Results From PROPHETIC Trial, Multicenter Assessment Of NSCLC Patient Response To Immunotherapy

January 24, 2022

Space meat and hummus: Israel finalizes experiments for upcoming ISS mission

January 24, 2022

Next Israeli astronaut’s 35 experiments revealed

January 28, 2022

2022 Predictions for AI and Machine Learning in Healthcare

February 3, 2022

3 Researchers Developing Innovative Strategies In Cancer Therapy

Oncology Peer Review On-The-Go: Ofer Sharon, MD, Discusses OncoHost and PROPHETIC Trial for NSCLC

Tech Transfer Roundup: MD Anderson, Moffitt Lead Busy Academic Cancer Partnering Space

Lifting the veil of uncertainty around cancer treatments

Driving Progress in Personalized Cancer Therapy

Nobel laureate Prof. Aaron Ciechanover to discuss advances in precision medicine

OncoHost Announces AI-Based Clinical Trial Collaboration to Analyze Immunotherapy Resistance

OncoHost enters trial partnership to evaluate resistance to immunotherapy

In Brief This Week: Qiagen, Renalytix, OpGen, PerkinElmer, Avacta, Paige, More

PROPHETIC Study of Immunotherapy Diagnostic Adds New Site in Buffalo, NY

‘Bio’ food, precision oncology to take center stage at biomed summit in Tel Aviv

Israeli startups eye growing precision oncology market

Israeli biotech startup OncoHost raises $35 million in funding to personalize cancer treatment using AI

Precision oncology platform OncoHost scores $35 million

OncoHost Raises $35M for AI-Powered Precision Oncology Platform

OncoHost Raises $35M in Series C Financing

$35 Million In New Funding For AI To Personalize Cancer Treatment

OncoHost Raises $35M in Series C Funding

Can OncoHost's PROphet predict host response to cancer treatments? Investors are waiting to find out

OncoHost Raises $35 Million Series C Funding Round to Launch Blood Test That May Rewrite the Standard of Care for Precision Oncology

Oncohost’s $35M series C predicts expansion of Prophet study

OncoHost Raises $35M For Precision Oncology Diagnostic Solution

Personalized cancer therapy co OncoHost raises $35m

FORTUNE Term Sheet Newsletter

OncoHost nabs $35M in funding round

Global Roundup: Medtronic Kicks Off Aortic Stenosis Study in Japan

Thought Leadership

AI tool helps doctors pick optimum cancer treatment for patients

Observational study demonstrates clinical validity and utility of OncoHost’s PROphet NSCLC test

Study in JCO® Precision Oncology Validates Clinical Efficacy of OncoHost’s PROphet® NSCLC Test

Study Demonstrates Clinical Validity of OncoHost’s NSCLC Test

OncoHost Wins AI Excellence Award

February 26, 2024

Predicting immunotherapy success via biomarkers

February 22, 2024

New cancer research for personalized care

February 22, 2024

Study: Protein Indicates Likely Success of Cancer Immunotherapy

January 26, 2024

OncoHost’s CEO Is PROphet-ic About His Diagnostic’s Potential To Transform Care

January 15, 2024

OncoHost: Guiding oncology treatment decisions with one blood draw

January 4, 2024

Predicting Immune-Related Adverse Events Through Machine Learning With OncoHost: Dr. Waqas Haque, Dr. Matthew Hadfield, and Dr. Ofer Sharon

AI & Big Data - A Bright New Diagnosis? Roundtable

December 8, 2019

First-Of-Its-Kind Lab To Improve Personalized Cancer Therapy Opens In Israel

December 31, 2019

Israeli algorithm may predict if cancer patients will respond to treatment

January 21, 2020

OncoHost, RayBiotech Win $1M From BIRD Foundation

January 21, 2020

OncoHost, RayBiotech Awarded $1 Million Grant for Precision Oncology

February 5, 2020

Top 5 Recent Advances In Israeli Cancer Research And Treatment

February 10, 2020

Startup develops blood test that aims to undermine tumors’ resilience

February 18, 2020

Backed by EU funds, Israeli researcher tackles treatment-resistant cancer

February 23, 2020

$8m in BIRD grants go to Israeli-US collaborations in agtech and health

Personalized Cancer Treatment, A Real Possibility?

Developing Personalized Strategies To Maximize Cancer Therapy Success

PART 1: Yuval Shaked, ASCO 2020: Host Response Profiling for Melanoma Patients

PART 2: Yuval Shaked, ASCO 2020: Host Response Profiling for Melanoma Patients

By Next Year, Will Doctors Finally Have The Technology To Fully Personalize Treatments For Lung Cancer Patients?

October 6, 2020

OncoHost Data on Host Immunotherapy Response to be Presented This Week

November 4, 2020

Oncohost platform improves immunotherapy response predictions

November 12, 2020

Israeli blood test offers better choices to fight cancer

November 15, 2020

OncoHost Offers New Hope For Cancer Sufferers

December 8, 2020

Dr. Ofer Sharon, CEO of OncoHost – Interview Series

December 31, 2020

OncoHost - Personalized cancer therapy for more effective treatment

January 12, 2021

Nobel prizewinner Ciechanover hails ‘much more precise’ cancer treatment

January 19, 2021

Israeli Startup OncoHost Raises $8M For AI Precision Oncology Platform

January 19, 2021

Israel-based OncoHost closes $8M in Series B funding to provide personalized cancer therapy for more effective treatment

January 19, 2021

OncoHost Raises $8 Million in Series B Funding Round

January 19, 2021

OncoHost raises $8 million to develop AI that predicts cancer treatment responses

January 20, 2021

OncoHost Secures $8M in Series B Funding

January 20, 2021

The evolution of machine learning in oncology: an interview with Dr Ofer Sharon

January 21, 2021

Money on the Move: January 15-20

January 26, 2020

US-Israel Foundation To Invest $8M In 9 New Joint Initiatives

January 21, 2021

OurCrowd leads $8M Series B in Israeli personalized cancer therapy startup

January 22, 2021

Oncohost nabs $8M series B round for AI-powered precision oncology platform

January 22, 2021

OncoHost Secures $8 Million Series B Funding Round

January 26, 2021

Health IT Appointments and Hires

February 1, 2021

January 2021 smiles upon Israeli startups: 4 new Unicorns and over $1B in funding

February 17, 2021

Dr. Ofer Sharon, CEO of OncoHost, Discusses Technology to Improve Cancer Care

How an AI tool predicts responses to cancer treatment

Which Israeli technologies will soon be going to space?

The Impact of Technology on Healthcare

NHS opens eight UK clinical trial sites to assess cancer patient response to immunotherapy in collaboration with OncoHost

NHS Opens Eight UK Clinical Trial Sites to Assess Cancer Patient Response to Immunotherapy in Collaboration with OncoHost

NHS opens 8 clinical trial sites to assess cancer treatment

Israel’s OncoHost, UK’s NHS to study cancer patient responses to immunotherapies

Oncohost opens trial sites for study evaluating its AI proteomics profiling technology

OncoHost's Focus on the Patient Offers Precision Oncology to Combat Cancer

August 19, 2021

OncoHost awarded Best Practices Technology Innovation Leadership Award in the AI-based precision oncology industry by Frost & Sullivan

August 20, 2021

OncoHost Wins Frost & Sullivan 2021 Technology Innovation Leadership Award for Excellence in Best Practices

August 25, 2021

Israeli Startup OncoHost Eyeing 2022 Commercial Launch of Immunotherapy Response Prediction Test

September 20, 2021

OncoHost Further Assessing Protein Signature for Predicting NSCLC Patients' Immunotherapy Response

September 20, 2021

Oncohost platform predicts response to lung cancer therapy

October 31, 2021

OncoHost’s Algorithms Predict Cancer Patients Response To Treatments

November 1, 2021

CTech’s 20 Minute Leaders Podcast Interview with Ofer Sharon, CEO of OncoHost

November 6, 2021

OncoHost: Personalizing cancer treatment based on host response

November 15, 2021

Dr. Ofer Sharon, CEO of OncoHost, Talks the Potential Impact of Precision Medicine on Cancer Therapy

December 1, 2021

OncoHost: David Gandara

December 7, 2021

Health IT Appointments and Hires

December 13, 2021

OncoHost, Heidelberg University Hospital Strike Lung Cancer Biomarker Alliance

December 16, 2021

Global Roundup: Aussie Biopharma Raises $25 Million to Expand in US

December 17, 2021

Israeli research institute makes great contributions to cancer research

December 20, 2021

OncoHost Collaborates with Lung Biobank Heidelberg to Discover Lung Cancer Biomarkers

January 17, 2022

OncoHost Announces Interim Results From PROPHETIC Trial, Multicenter Assessment Of NSCLC Patient Response To Immunotherapy

January 24, 2022

Space meat and hummus: Israel finalizes experiments for upcoming ISS mission

January 24, 2022

Next Israeli astronaut’s 35 experiments revealed

January 28, 2022

2022 Predictions for AI and Machine Learning in Healthcare

February 3, 2022

3 Researchers Developing Innovative Strategies In Cancer Therapy

Oncology Peer Review On-The-Go: Ofer Sharon, MD, Discusses OncoHost and PROPHETIC Trial for NSCLC

Tech Transfer Roundup: MD Anderson, Moffitt Lead Busy Academic Cancer Partnering Space

Lifting the veil of uncertainty around cancer treatments

Driving Progress in Personalized Cancer Therapy

Nobel laureate Prof. Aaron Ciechanover to discuss advances in precision medicine

OncoHost Announces AI-Based Clinical Trial Collaboration to Analyze Immunotherapy Resistance

OncoHost enters trial partnership to evaluate resistance to immunotherapy

In Brief This Week: Qiagen, Renalytix, OpGen, PerkinElmer, Avacta, Paige, More

PROPHETIC Study of Immunotherapy Diagnostic Adds New Site in Buffalo, NY

‘Bio’ food, precision oncology to take center stage at biomed summit in Tel Aviv

Israeli startups eye growing precision oncology market

Israeli biotech startup OncoHost raises $35 million in funding to personalize cancer treatment using AI

Precision oncology platform OncoHost scores $35 million

OncoHost Raises $35M for AI-Powered Precision Oncology Platform

OncoHost Raises $35M in Series C Financing

$35 Million In New Funding For AI To Personalize Cancer Treatment

OncoHost Raises $35M in Series C Funding

Can OncoHost's PROphet predict host response to cancer treatments? Investors are waiting to find out

OncoHost Raises $35 Million Series C Funding Round to Launch Blood Test That May Rewrite the Standard of Care for Precision Oncology

Oncohost’s $35M series C predicts expansion of Prophet study

OncoHost Raises $35M For Precision Oncology Diagnostic Solution

Personalized cancer therapy co OncoHost raises $35m

FORTUNE Term Sheet Newsletter

OncoHost nabs $35M in funding round

Global Roundup: Medtronic Kicks Off Aortic Stenosis Study in Japan

Thought Leadership

Meetings & Events

In the News

AI tool helps doctors pick optimum cancer treatment for patients

Observational study demonstrates clinical validity and utility of OncoHost’s PROphet NSCLC test

Study in JCO® Precision Oncology Validates Clinical Efficacy of OncoHost’s PROphet® NSCLC Test

OncoHost Wins AI Excellence Award

Study Demonstrates Clinical Validity of OncoHost’s NSCLC Test

February 26, 2024

Predicting immunotherapy success via biomarkers

February 22, 2024

Study: Protein Indicates Likely Success of Cancer Immunotherapy

February 22, 2024

New cancer research for personalized care

January 26, 2024

OncoHost’s CEO Is PROphet-ic About His Diagnostic’s Potential To Transform Care

January 15, 2024

OncoHost: Guiding oncology treatment decisions with one blood draw

January 4, 2024

Predicting Immune-Related Adverse Events Through Machine Learning With OncoHost: Dr. Waqas Haque, Dr. Matthew Hadfield, and Dr. Ofer Sharon

December 5, 2023

Addressing One of the Most Common Dilemmas Faced by Oncologists

Thought Leadership

February 13, 2024

Unlocking the Potential of AI-Driven Biomarkers: A New Era in Personalized Cancer Care

A Multicomponent Biomarker Approach Will Shift Cancer Care

February 27, 2023

A New Approach to Personalized Immunotherapy

November 29, 2022

Bringing Hope to Patients with Stage IV Non–Small-Cell Lung Cancer

October 25, 2022

This Time, It’s Personal

August 30, 2022

Collaboration is the key to advancing cancer care

How Can We Investigate Biomarkers For Lung Cancer Patients More Effectively?

Revealing the Blind Spot in Cancer Treatment with Host Response Profiling

January 13, 2021

Treating cancer with precision: It’s time for host response profiling

February 13, 2020

Cancer Therapy in 2020: The promise of host-response profiling

Press Releases

NHS Opens Eight UK Clinical Trial Sites to Assess Cancer Patient Response to Immunotherapy in Collaboration with OncoHost

January 19, 2021

OncoHost Secures $8 Million Series B Funding Round to Advance its AI-Powered Precision Oncology Platform

January 11, 2021

OncoHost Welcomes Nobel Prize Winner to Scientific Advisory Board

November 9, 2020

OncoHost to Present Data on Predicting Host Response to Immunotherapy in Melanoma Patients at SITC 2020

October 5, 2020

OncoHost to Present Data on Predicting Host Response to Immunotherapy at the MAP 2020 Virtual Congress - ESMO

September 17, 2020

OncoHost to Present Data on Host Response Profiling for NSCLC Patients at ESMO Virtual Congress 2020

OncoHost to Present Data on Host Response Profiling for Melanoma Patients at 2020 ASCO Annual Meeting

January 21, 2020

OncoHost and RayBiotech Awarded $1 Million Grant From the BIRD Foundation to Advance Precision Oncology for Patients Receiving Immunotherapy

January 21, 2020

BIRD - Israel-U.S. Binational Industrial R&D Foundation to Invest $8 million in 9 New Projects

December 4, 2019

OncoHost Opens First-of-its-Kind Proteomics Laboratory for Host Response Analysis for Cancer Therapy

October 31, 2019

OncoHost: Nature Reviews Cancer Article Outlines Host Response Analysis as New Tool for Precision Medicine in Oncology

Meetings & Events

2024 Annual Breath of Hope Ohio Gala

MedCity INVEST 2024

ASCO Annual Meeting 2024

Awards

2024 Artificial Intelligence Excellence Award

December 3, 2023

Top 10 Precision Oncology Solution Providers 2023

October 5, 2023

2023 Merit Awards for Technology: Gold Winner in Biotech

Biotechnology Awards 2023: Best Precision Oncology Solutions Developer - Middle East

January 11, 2023

2023 BIG Innovation Award for PROphet® Platform

November 1, 2021

Health Tech Digital Awards 2021

September 30, 2021

ESMO 2021 Best Poster Award: Biomarker Category

September 27, 2021

Semifinalist: AACC Disruptive Technology Awards 2021

August 18, 2021

Frost & Sullivan 2021 Technology Innovation Leadership Award for Excellence in Best Practices

PROphet^®

PROphet^® Technology

PROphetNSCLC^™ Test

Resources

Science

Clinical Studies

News

Thought Leadership

Meetings & Events

Company

All Rights Reserved © 2024